指南与共识儿科与产科急症心脑血管急症

美国胸外科医师协会(AATS)2022专家共识:婴儿和新生儿法洛四联症的管理

The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot.
指南 / 共识 · J Thorac Cardiovasc Surg · 2022-10-26
一句话结论AATS 2022专家共识:无症状TOF婴儿3–6月龄行根治术合理;多数有症状新生儿可姑息或一期根治,高危者倾向姑息。

该共识由美国胸外科医师协会(AATS)委托TOF临床实践标准委员会制定,旨在为法洛四联症合并肺动脉狭窄(TOF)婴儿和新生儿的管理提供框架,聚焦干预时机与类型、高危患者管理、干预技术要点及结局评估最佳实践。委员会通过PubMed、Embase、Scopus和Web of Science检索2000年及以后的英文文献,排除肺动脉闭锁、肺动脉瓣缺如、房室间隔缺损及成人TOF相关文献及综述等非原始来源,从近20,000条结果中纳入163篇;采用改良Delphi法形成专家共识声明,每条声明需80%成员投票且75%同意。共识推荐无症状婴儿3–6月龄行完全手术矫正合理,多数有症状新生儿姑息与一期根治均为有用选择,低出生体重、早产、小或不连续肺动脉、染色体异常、其他先天异常或颅内出血、脓毒症等合并症者视为高危、倾向姑息。完整手术矫正经心房与经心室途径均有效,应尽量行最小心室切开、尽可能保留肺动脉瓣,术毕确认右室流出道梗阻充分解除,发现显著固定解剖梗阻应进一步干预。

要点

  • 无症状TOF婴儿在3–6月龄行完全手术矫正合理,可减少住院时间、不良事件率和需用跨环补片。
  • 多数有症状新生儿,姑息治疗和一期完全手术矫正均为有用的治疗选择。
  • 低出生体重或早产、小或不连续肺动脉、染色体异常、其他先天异常、颅内出血、脓毒症或其他终末器官受累者应考虑为高危患者,高危者可能更倾向姑息治疗。
  • 解剖条件合适的患者,导管介入操作可能优于外科姑息治疗。
  • 完全手术矫正经心房和经心室途径均有效,但应使用尽可能小的心室切开;尽可能保留肺动脉瓣,无法保留时可考虑重建。

适用人群与场景

  • 婴儿和新生儿法洛四联症合并肺动脉狭窄(TOF)患者。
  • 有症状新生儿:多数可考虑姑息治疗或一期完全手术矫正。
  • 无症状婴儿:可考虑在3–6月龄行完全手术矫正。
  • 高危患者:低出生体重或早产、小或不连续肺动脉、染色体异常、其他先天异常、或颅内出血、脓毒症、其他终末器官受累等合并症者。

处置流程与药物剂量

  • 无症状婴儿:完全手术矫正年龄3–6月龄,以减少住院时间、不良事件率和需用跨环补片。
  • 多数有症状新生儿:姑息治疗和一期完全手术矫正均为有用的治疗选择。
  • 高危患者(低出生体重或早产、小或不连续肺动脉、染色体异常、其他先天异常、颅内出血、脓毒症或其他终末器官受累):可能更倾向姑息治疗;解剖条件合适者,导管介入操作可能优于外科姑息治疗。
  • 完全手术矫正:经心房和经心室途径均有效,但应使用尽可能小的心室切开。
  • 完全手术矫正:尽可能保留肺动脉瓣;如无法保留,可考虑重建。
  • 手术结束时:应确认右室流出道梗阻充分解除;识别到显著固定解剖梗阻应促使进一步干预。

红旗征与不能漏的情况

  • 低出生体重或早产、小或不连续肺动脉、染色体异常、其他先天异常、颅内出血、脓毒症或其他终末器官受累提示高危,可能更倾向姑息治疗。
  • 手术结束时发现显著固定解剖梗阻,应进一步干预。

研究设计与关键结果

  • 制定机构:美国胸外科医师协会(AATS)委托TOF临床实践标准委员会;委员会为多国多学科心脏病学和外科专家组成。
  • 方法:在医学图书馆员协助下检索PubMed、Embase、Scopus和Web of Science,限定英文和2000年及以后,排除肺动脉闭锁、肺动脉瓣缺如、房室间隔缺损、成人TOF及综述等非原始来源,近20,000条结果中纳入163篇。
  • 证据分级:采用改良Delphi法形成带推荐等级和证据水平的专家共识声明,每条声明需80%成员投票且75%同意。
  • 共识内容覆盖干预时机与类型、高危患者管理、干预技术要点及结局评估最佳实践,并识别未来研究问题。

证据类型、等级与局限

  • 证据类型:专家共识(指南/共识文件)。
  • 推荐等级和证据水平:采用改良Delphi法制定,每条声明需80%成员投票且75%同意;具体条目的推荐等级和证据水平未在正文中逐条列出。
  • 局限:原文未报告局限性;原文指出机构经验差异可能影响该框架在临床实践中的应用。

对床旁实践的改变

  • 无症状TOF婴儿可在3–6月龄行完全手术矫正,以减少住院时间、不良事件率和跨环补片需求。
  • 有症状新生儿多数可考虑姑息或一期完全手术矫正;高危患者可能更倾向姑息治疗。
  • 解剖条件合适的高危患者,导管介入操作可能优于外科姑息治疗。
  • 完全手术矫正应使用尽可能小的心室切开,尽可能保留肺动脉瓣,无法保留时可考虑重建。
  • 术毕应确认右室流出道梗阻充分解除,发现显著固定解剖梗阻应进一步干预。
  • 原文指出机构经验差异可能影响该框架在临床实践中的应用。

指南或共识出处

  • 美国胸外科医师协会(AATS)2022专家共识文件:婴儿和新生儿法洛四联症的管理(J Thorac Cardiovasc Surg)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Despite decades of experience, aspects of the management of tetralogy of Fallot with pulmonary stenosis (TOF) remain controversial. Practitioners must consider newer, evolving treatment strategies with limited data to guide decision making. Therefore, the TOF Clinical Practice Standards Committee was commissioned by the American Association for Thoracic Surgery to provide a framework on this topic, focused on timing and types of interventions, management of high-risk patients, technical considerations during interventions, and best practices for assessment of outcomes of the interventions. In addition, the group was tasked with identifying pertinent research questions for future investigations. It is recognized that variability in institutional experience could influence the application of this framework to clinical practice.

METHODS: The TOF Clinical Practice Standards Committee is a multinational, multidisciplinary group of cardiologists and surgeons with expertise in TOF. With the assistance of a medical librarian, a citation search in PubMed, Embase, Scopus, and Web of Science was performed using key words related to TOF and its management; the search was restricted to the English language and the year 2000 or later. Articles pertaining to pulmonary atresia, absent pulmonary valve, atrioventricular septal defects, and adult patients with TOF were excluded, as well as nonprimary sources such as review articles. This yielded nearly 20,000 results, of which 163 were included. Greater consideration was given to more recent studies, larger studies, and those using comparison groups with randomization or propensity score matching. Expert consensus statements with class of recommendation and level of evidence were developed using a modified Delphi method, requiring 80% of the member votes with 75% agreement on each statement.

RESULTS: In asymptomatic infants, complete surgical correction between age 3 and 6 months is reasonable to reduce the length of stay, rate of adverse events, and need for a transannular patch. In the majority of symptomatic neonates, both palliation and primary complete surgical correction are useful treatment options. It is reasonable to consider those with low birth weight or prematurity, small or discontinuous pulmonary arteries, chromosomal anomalies, other congenital anomalies, or other comorbidities such as intracranial hemorrhage, sepsis, or other end-organ compromise as high-risk patients. In these high-risk patients, palliation may be preferred; and, in patients with amenable anatomy, catheter-based procedures may prove favorable over surgical palliation.

CONCLUSIONS: Ongoing research will provide further insight into the role of catheter-based interventions. For complete surgical correction, both transatrial and transventricular approaches are effective; however, the smallest possible ventriculotomy should be utilized. When possible, the pulmonary valve should be spared; and if unsalvageable, reconstruction can be considered. At the conclusion of the operation, adequate relief of the right ventricular outflow obstruction should be confirmed, and identification of a significant fixed anatomical obstruction should prompt further intervention. Given our current knowledge and the gaps identified, we propose several key questions to be answered by future research and potentially by a TOF registry: When to palliate or proceed with complete surgical correction, as well as the ideal type of palliation; the optimal surgical approach for complete repair for the best long-term preservation of right ventricular function; and the utility, efficacy, and durability of various pulmonary valve preservation and reconstruction techniques.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

参考来源

  1. Miller JR, Stephens EH, Goldstone AB, et al. The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2022. PMID: 36522807. doi:10.1016/j.jtcvs.2022.07.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。